• Seeking Alpha

Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

Seeking Alpha / 32 minutes ago 1 Views

Resolution of CRL Manufacturing issues in progress - Type A meeting requested

Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Pasithea Therapeutics Announces Initiation of Phase 1/1B Study of PAS-004 in Adult NF1 Patients and Activation of First Clinical Trial Site
Next post
EES Europe 2025: Sunwoda Energy представляет инновационные решения для хранения энергии для устойчивого будущего

Comments

Just Posted

  • Swvl Grows 12.4% Quarter on Quarter in IFRS Revenue, 47% Quarter on Quarter Growth in Revenue in Constant Currency, and Achieves $0.8 Million in Net Profit in Q1 2025

    3 hours from now

  • Notice Regarding Uab „orkela“ Financial Statements for 3-Month Period Ended 31 March 2025

    3 hours from now

  • PRANEŠIMAS DĖL UAB „ORKELA“ FINANSINĖS ATASKAITOS UŽ 3 MĖNESIŲ LAIKOTARPĮ, PASIBAIGUSĮ 2025 M. KOVO 31 D.

    3 hours from now

  • Aurskog Sparebank: Delårsrapport pr 31.03.2025

    3 hours from now

  • Transaction in Own Shares

    3 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1610

Categories

  • Seeking Alpha 1610

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts